(Q67897353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824806%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Effects of doxazosin on blood pressure, renin-angiotensin-aldosterone and urinary kallikrein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824806%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

18 September 2019

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

3 December 2022

author name string

M. C. Oliveros-Palacios

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1824806

3 December 2022

N. Godoy-Godoy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1824806

3 December 2022

J. A. Colina-Chourio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1824806

3 December 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824806%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

15 January 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1824806

full work available at URL

3 December 2022

https://api.elsevier.com/content/article/PII:000291499190438Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

https://api.elsevier.com/content/article/PII:000291499190438Q?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

American Journal of Cardiology

3 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824806%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824806%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

157-161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824806%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824806%20AND%20SRC:MED&resulttype=core&format=json

Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment.

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart Failure

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Prazosin: the first-dose phenomenon

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Pharmacokinetic overview of doxazosin

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

A pharmacodynamic and pharmacokinetic assessment of a new alpha- adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Central and Renal Circulation, Renin and Aldosterone in Plasma during Prazosin Treatment in Essential Hypertension

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Effectiveness of doxazosin in systemic hypertension

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Clinical pharmacology of doxazosin in patients with essential hypertension.

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Studies on the renin-aldosterone system in the acute nephritic syndrome

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Radioimmunoassay of aldosterone in crude plasma extracts

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Methods for the Determination of Glandular Kallikrein by Means of a Chromogenic Tripeptide Substrate

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Decreased total and active urinary kallikrein in normotensive Dahl salt susceptible rats.

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Mechanism of alpha blockade for blood pressure control

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Evidence for a stimulatory effect of high potassium diet on renal kallikrein

3 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Short-term monotherapy with the potassium channel activator BRL 34915 on endocrine sodium regulation in essential hypertension

3 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90438-Q

3 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1824806%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference